SR59230A
CAS: 174689-39-5
Ref. 3D-ZGA68939
1mg | 213,00 € | ||
2mg | 341,00 € | ||
5mg | 480,00 € | ||
10mg | 711,00 € | ||
25mg | 1.276,00 € |
Informação sobre produto
- (2S)-1-(2-Ethylphenoxy)-3-[[(1S)-1,2,3,4-tetrahydro-1-naphthalenyl]amino]2-propanol ethanedioate (1:1)
- (2S)-1-(2-ethylphenoxy)-3-[(1S)-1,2,3,4-tetrahydronaphthalen-1-ylamino]propan-2-ol ethanedioate (salt)
- 2-Propanol, 1-(2-ethylphenoxy)-3-[(1,2,3,4-tetrahydro-1-naphthalenyl)amino]-, [S-(R*,R*)]-, ethanedioate (1:1) (salt)
- 2-Propanol, 1-(2-ethylphenoxy)-3-[[(1S)-1,2,3,4-tetrahydro-1-naphthalenyl]amino]-, (2S)-, ethanedioate (1:1)
- 2-Propanol, 1-(2-ethylphenoxy)-3-[[(1S)-1,2,3,4-tetrahydro-1-naphthalenyl]amino]-, (2S)-, ethanedioate (1:1) (salt)
- 3-(2-Ethylphenoxy)-1-[[(1S)-1,2,3,4-tetrahydronaphth-1-yl]amino]-(2S)-2-propanol oxalate salt
- SR59230AHCl
- Sr 59230A
- Sr 59230A Hydrochloride
SR59230A is a monoclonal antibody that has been shown to inhibit the activity of the protein uncoupling protein 2 (UCP2). This leads to an increase in cellular energy expenditure, thereby lowering blood pressure and improving metabolic disorders. SR59230A also has anti-inflammatory effects, which may be due to its inhibition of pro-inflammatory cytokines, such as TNF-α and IL-1β. SR59230A has been shown to reduce the levels of camp, a chemical that regulates metabolism, in mice with type 1 diabetes. SR59230A is being investigated for use in treating cardiac disease and other symptoms related to cardiovascular disease.
Propriedades químicas
Consulta técnica sobre: 3D-ZGA68939 SR59230A
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.